Gene expression and regulation in systemic lupus erythematosus

European Journal of Clinical Investigation

Volumn 43, Issue 10, 2013, Pages 1084-1096

  Frangou, Eleni A ^a   Bertsias, George K ^b   Boumpas, Dimitrios T ^a,b  

^a UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF CRETE   (Greece)

Author keywords

Apoptosis; Autoimmunity; Interferon; Microarrays; Transcriptomics

Indexed keywords

ADENOSINE TRIPHOSPHATE; CD18 ANTIGEN; CD27 ANTIGEN; CD44V ANTIGEN; CHEMOKINE; CHEMOKINE RECEPTOR CCR7; COMPLEMENT; COMPLEMENTARY DNA; CYTOCHROME P450 4A11; DNA; HEAT SHOCK PROTEIN 27; HISTONE; INTERFERON REGULATORY FACTOR 2; INTERFERON REGULATORY FACTOR 3; INTERFERON REGULATORY FACTOR 7; INTERLEUKIN 18; INTERLEUKIN 4; INTERLEUKIN 7 RECEPTOR; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3; MATRILYSIN; MICRORNA; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22; NOTCH1 RECEPTOR; PROTEIN KINASE ZAP 70; STAT1 PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE 4; TOLL LIKE RECEPTOR 10; TOLL LIKE RECEPTOR 2; TRANSCRIPTOME; UNINDEXED DRUG;

ACETYLATION; BLOOD; BONE MARROW CELL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHROMATIN STRUCTURE; DNA METHYLATION; DNA MODIFICATION; ENDOPLASMIC RETICULUM; EPIGENETICS; GENE CONTROL; GENE EXPRESSION; GENETIC VARIABILITY; HISTONE MODIFICATION; HUMAN; INTERFERON PRODUCTION; LEUKOCYTE; LUPUS ERYTHEMATOSUS NEPHRITIS; METHYLATION; MONONUCLEAR CELL; NONHODGKIN LYMPHOMA; NONHUMAN; PATHOGENESIS; PHENOTYPE; PHENOTYPIC VARIATION; PRIORITY JOURNAL; REGULATOR GENE; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; UPREGULATION;

APOPTOSIS; AUTOIMMUNITY; INTERFERON; MICROARRAYS; TRANSCRIPTOMICS;

BONE MARROW CELLS; DNA METHYLATION; GENE EXPRESSION; GENE EXPRESSION REGULATION; HISTONES; HUMANS; IMMUNITY, CELLULAR; LEUKOCYTES, MONONUCLEAR; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICRORNAS; PHENOTYPE;

EID: 84884700345     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/eci.12130     Document Type: Review

References (69)

1. Bertsias GK, Salmon JE, Boumpas DT. Therapeutic opportunities in systemic lupus erythematosus: state of the art and prospects for the new decade. Ann Rheum Dis 2010;69:1603-11.
2. Liu Z, Davidson A. Taming lupus - a new understanding of pathogenesis is leading to clinical advances. Nat Med 2012;18: 871-82.
3. Moser KL, Kelly JA, Lessard CJ, Harley JB. Recent insights into the genetic basis of systemic lupus erythematosus. Genes Immun 2009;10:373-9.
4. Deng Y, Tsao BP. Genetic susceptibility to systemic lupus erythematosus in the genomic era. Nat Rev Rheumatol 2010;6: 683-92.
5. Guerra SG, Vyse TJ, Cunninghame Graham DS. The genetics of lupus: a functional perspective. Arthritis Res Ther 2012;14:211.
6. Costa V, Aprile M, Esposito R, Ciccodicola A. RNA-Seq and human complex diseases: recent accomplishments and future perspectives. Eur J Hum Genet 2013;21:134-42.
7. Kilpinen H, Dermitzakis ET. Genetic and epigenetic contribution. Hum Mol Genet 2012;21:R24-8.
8. Baechler EC, Batliwalla FM, Karypis G, Gaffney PM, Ortmann WA, Espe KJ et al. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. PNAS 2003;100:2610-5.
9. Benett L, Palucka KA, Arce E, Cantrell V, Borvak J, Banchereau J et al. Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med 2003;197:711-23.
10. Han GM, Chen SL, Shen N, Ye S, Bao CD, Gu YY. Analysis of gene expression profiles in human systemic lupus erythematosus using oligonucleotide microarray. Genes Immun 2003;4:177-86.
11. Rus V, Chen H, Zernetkina V, Magder LS, Mathai S, Hochberg MC et al. Gene expression profiling in peripheral blood mononuclear cells from lupus patients with active and inactive disease. Clin Immunol 2004;112:231-4.
12. Lee HM, Sugino H, Aoki C, Nishimoto N. Underexpression of mitochondrial-DNA encoded ATP synthesis-related genes and DNA repair genes in systemic lupus erythematosus. Arthritis Res Ther 2011;13:R63.
13. Maas K, Chen H, Shyr Yu, Olsen NJ, Aune T. Shared gene expression profiles in individuals with autoimmune disease and unaffected first-degree relatives of individuals with autoimmune disease. Hum Mol Genet 2005;14: 1305-14.
14. Arasappan D, Tong W, Mummaneni P, Fang H, Amur S. Metaanalysis of microarray data using a pathway-based approach identifies a 37-gene expression signature for systemic lupus erythematosus in human peripheral blood mononuclear cells. BMC Med 2011;9:65.
15. Lyons PA, McKinney EF, Rayner TF, Hatton A, Woffendin HB, Koukoulaki M et al. Novel expression signatures identified by transcriptional analysis of separated leukocyte subsets in systemic lupus erythematosus and vasculitis. Ann Rheum Dis 2010;69:1208-13.
16. Li QZ, Zhou J, Lian Y, Zhang B, Branch VK, Carr-Johnson F et al. Interferon signature gene expression is correlated with autoantibody profiles in patients with incomplete lupus syndromes. Clin Exp Immunol 2009;159:281-91.
17. Bilqic H, Ytterberg SR, Amin S, McNallan KT, Wilson KT, Wilson JC et al. Interleukin-6 and type I Interferon-regulated genes and chemokines mark disease activity in dermatomyositis. Arthritis Rheum 2009;60:3436-46.
18. McKinney EF, Lyons PA, Carr EJ, Hollis JL, Jayne DRW, Willcocks LC et al. A CD8 T cell transcription signature predicts prognosis in autoimmune disease. Nat Med 2010;16:586-91.
19. Garaud JC, Schickel JN, Blaison G, Knapp AM, Dembele D, Ruer-Laventie J et al. B cell signature during inactive systemic lupus is heterogeneous: toward a biological dissection of lupus. PLoS ONE 2011;6:e23900.
20. Lugar PL, Love C, Grammer AC, Dave SS, Lipsky PE. Molecular characterization of circulating plasma cells in patients with active systemic lupus erythematosus. PLoS ONE 2012;7:e44362.
21. Lood C, Amisten S, Gullstrand B, Jonsen A, Allhorn M, Truedsson L et al. Platelet transcriptional profile and protein expression in patients with systemic lupus erythematosus: up-regulation of the type I interferon system is strongly associated with vascular disease. Blood 2010;116:1951-7.
22. Toukap AN, Galant C, Theate I, Maudoux AL, Lories RJU, Houssiau FA et al. Identification of distinct gene expression profiles in the synovium of patients with systemic lupus erythematosus. Arthritis Rheum 2007;56:1579-88.
23. Alexander JJ, Saxena AK, Bao L, Jacob A, Haas M, Quigg RJ. Prominent renal expression of a murine leukemia retrovirus in experimental systemic lupus erythematosus. J Am Soc Nephrol 2002;13:2869-77.
24. Peterson KS, Huang JF, Zhu J, D'Agati V, Liu X, Miller N et al. Characterization of heterogeneity in the molecular pathogenesis of lupus nephritis from transcriptional profiles of laser-captured glomeruli. J Clin Invest 2004;113:1722-33.
25. Berthier CC, Bethunaickan R, Gonzalez-Rivera T, Nair V, Ramanujam M, Zhang W et al. Cross-species transcriptional network analysis defines shared inflammatory responses in murine and human lupus nephritis. J Immunol 2012;189:988-1001.
26. Teramoto K, Negoro N, Kitamoto K, Iwai T, Iwao H, Okamura M et al. Microarray analysis of glomerular gene expression in murine lupus nephritis. J Pharmacol Sci 2008;106:56-67.
27. Kahlenberg JM, Thacker SG, Berthier CC, Cohen CD, Kretzler M, Kaplan MJ. Inflammasome activation of IL-18 results in endothelial progenitor cell dysfunction in systemic lupus erythematosus. J Immunol 2011;187:6143-56.
28. Voulgarelis M, Giannouli S, Tasidou A, Anagnostou D, Ziakas PD, Tzioufas AG. Bone marrow histological findings in systemic lupus erythematosus with hematological abnormalities: a clinicopathological study. Am J Hematol 2006;81:590-7.
29. Nakou M, Knowlton N, Frank MB, Bertsias G, Osban J, Sandel CE et al. Gene expression in human lupus: bone marrow differentiates active from inactive patients and displays apoptosis and granulopoiesis signatures. Arthritis Rheum 2008;58:3541-9.
30. Nakou M, Bertsias G, Stagakis I, Centola M, Tassiulas I, Hatziapostolou M et al. Gene network analysis of bone marrow mononuclear cells reveals activation of multiple kinase pathways in human systemic lupus erythematosus. PLoS ONE 2010;5: e13351.
31. Lu Q, Kaplan M, Ray D, Zacharek S, Gutsch D, Richardson B. Demethylation of ITGAL (CD11a) regulatory sequences in systemic lupus erythematosus. Arthritis Rheum 2002;46:1282-91.
32. Gorelik G, Fang JY, Wu A, Sawalha AH, Richardson B. Impaired T cell protein kinase C delta activation decreases ERK pathway signaling in idiopathic and hydralazine-induced lupus. J Immunol 2007;179:5553-63.
33. Sawalha AH, Jeffries M, Lu Q, Gorelik G, Ray D, Osban J et al. Defective T-cell ERK signaling induces interferon-regulated gene expression and overexpression of methylation-sensitive genes similar to lupus patients. Genes Immun 2008;9:368-78.
34. Li Y, Zhao H, Yin H, Gao F, Wu X, Luo Y et al. Overexpression of the growth arrest and DNA damage-induced 45alpha gene contributes to autoimmunity by promoting DNA methylation in lupus T-cells. Arthritis Rheum 2010;62:1438-47.
35. Balada E, Castro-Marrero J, Felip L, Ordi-Ros J, Vilardell-Tarres M. Associations between the expression of epigenetically regulated genes and the expression of DNMTs and MBDs in systemic lupus erythematosus. PLoS ONE 2012;7:e45897.
36. Kaplan MJ, Lu Q, Wu A, Attwood J, Richardson B. Demethylation of promoter regulatory elements contributes to perforin overexpression in CD4+ lupus T-cells. J Immunol 2004;172:3652-61.
37. Lu Q, Wu A, Richardson BC. Demethylation of the same promoter sequence increases CD70 expression in lupus T-cells and T-cells treated with lupus-inducing drugs. J Immunol 2005;174:6212-9.
38. Zhao M, Tang J, Gao F, Wu X, Liang Y, Yin H et al. Hypomethylation of IL10 and IL13 promoters in CD4+ T-cells of patients with systemic lupus erythematosus. J Biomed Biotechnol 2010;2010: Article ID 931018, doi: 10.1155/2010/931918.
39. Liu Y, Kuick R, Hanash S, Richardon B. DNA methylation inhibition increases KIR expression through effects on both promoter methylation and transcription factors. Clin Immunol 2009;130:213-24.
40. Sunahori K, Juang YT, Kyttaris VC, Tsokos GC. Promoter hypomethylation results in increased expression of protein phosphatase 2A in T cells from patients with systemic lupus erythematosus. J Immunol 2011;186:4508-17.
41. Javierre BM, Fernandez AF, Richter J, Al-Shahrour F, Martin-Subero JI, Rodriguez-Ubreva J et al. Changes in the pattern of DNA methylation associate with twin discordance in systemic lupus erythematosus. Genome Res 2010;20:170-9.
42. Jeffries M, Dozmorov M, Tang Y, Merill JT, Wren JD, Sawalha AH. Genome-wide DNA methylation patterns in CD4+ T cells from patients with systemic lupus erythematosus. Epigenetics 2011;6:593- 601.
43. Lin SY, Hsieh SC, Lin YC, Lee CN, Tsai MH, Lai LC et al. A whole genome methylation analysis of systemic lupus erythematosus: hypomethylation of the IL10 and IL1R2 promoters is associated with disease activity. Genes Immun 2012;13:214-20.
44. Furukawa H, Oka S, Matsui T, Hashimoto A, Arinuma Y, Komiya A et al. Genome, epigenome and transcriptome analyses of a pair of monozygotic twins discordant for systemic lupus erythematosus. Hum Immunol 2013;74:170-5.
45. Sullivan KE, Suriano A, Dietzmann K, Lin J, Goldman D, Petri MA. The TNFa locus is altered in monocytes from patients with systemic lupus erythematosus. Clin Immunol 2007;123:74-81.
46. Zhang Z, Song L, Maurer K, Petri MA, Sullivan KE. Global H4 acetylation analysis by ChIP-chip in SLE monocytes. Genes Immun 2010;11:124-33.
47. Hu N, Qiu X, Luo Y, Yuan J, Li Y, Lei W et al. Abnormal histone modification patterns in lupus CD4+ T-cells. J Rheumatol 2008;35:804-10.
48. Mishra N, Reilly CM, Brown DR, Ruiz P, Gilkeson GS. Histone deacetylase inhibitors modulate renal disease in the MRL-lpr/lpr mouse. J Clin Invest 2003;111:539-52.
49. Garcia BA, Busby SA, Shabanowitz J, Hunt DF, Mishra N. Resetting the epigenetic histone code in the MRL-lpr/lpr mouse model of lupus by histone deacetylase inhibition. J Proteome Res 2005;4:2032- 42.
50. Hedrich CM, Rauen T, Tsokos GC. cAMP-responsive element modulator (CREM)a protein signaling mediates epigenetic remodeling of the human interleukin-2 gene. J Biol Chem 2011;286:43429-36.
51. Hedrich CM, Rauen T, Kis-Toth K, Kyttaris VC, Tsokos GC. cAMPresponsive element modulator a (CREMa) suppresses IL-17F protein expression in T lymphocytes from patients with systemic lupus erythematosus (SLE). J Biol Chem 2012;287:4715-25.
52. Stagakis E, Bertsias G, Verginis P, Nakou M, Hatziapostolou M, Kritikos H et al. Identification of novel microRNA signatures linked to human lupus disease activity and pathogenesis: miR-21 regulates aberrant T cell responses through regulation of PDCD4 expression. Ann Rheum Dis 2011;70:1496-506.
53. Dai Y, Huang YS, Tang M, Lv TY, Hu CX, Tan YH et al. Microarray analysis of microRNA expression in peripheral blood cells of systemic lupus erythematosus patients. Lupus 2007;16:939-46.
54. Te JL, Dozmorov IM, Guthridge JM, Nguyen KL, Cavett JW, Kelly JA et al. Identification of unique microRNA signature associated with lupus nephritis. PLoS ONE 2010;5:e10344.
55. Tang Y, Luo X, Cui H, Ni X, Yuan M, Guo Y et al. MicroRNA-146a contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. Arthritis Rheum 2009;60:1065-75.
56. Zhao X, Tang Y, Qu B, Cui H, Wang S, Wang L et al. MicroRNA-125a contributes to elevated inflammatory chemokine RANTES levels via targeting KLF13 in systemic lupus erythematosus. Arthritis Rheum 2010;62:3425-35.
57. Fan W, Liang D, Tang Y, Qu Bo, Cui H, Luo X et al. Identification of microRNA-31 as a novel regulator contributing to impaired interleukin-2 production in T cells from patients with systemic lupus erythematosus. Arthritis Rheum 2012;64:3715-25.
58. Carlsen AL, Schetter AJ, Nielsen CT, Lood C, Knudsen S, Voss A et al. Circulating microRNA expression profiles associated with systemic lupus erythematosus. Arthritis Rheum 2013;65:1324-34.
59. Pan W, Zhu S, Yuan M, Cui H, Wang L, Luo X et al. MicroRNA-21 and microRNA-148a contribute to DNA hypomethylation in lupus CD4+ T cells by directly and indirectly targeting DNA methyltransferase 1. J Immunol 2010;184:6773-81.
60. Zhao S, Wang Y, Liang Y, Zhao M, Long H, Ding S et al. MicroRNA-126 regulates DNA methylation in CD4+ T cells and contributes to systemic lupus erythematosus by targeting DNA methyltransferase 1. Arthritis Rheum 2011;63:1376-86.
61. Ding S, Liang Y, Zhao M, Liang G, Long H, Zhao S et al. Decreased microRNA-142-3p/5p expression causes CD4+ T cell activation and B cell hyperstimulation in systemic lupus erythematosus. Arthritis Rheum 2012;64:2953-63.
62. Dai Y, Sui W, Lan H, Yan Q, Huang H, Huang YS. Comprehensive analysis of microRNA expression patterns in renal biopsies of lupus nephritis patients. Rheumatol Int 2009;29:749-54.
63. Lu J, Kwan BCH, Lai FMM, Tam LS, Li EKM, Chow KM et al. Glomerular and tubulointerstitial miR-638, miR-198, and miR-146a expression in lupus nephritis. Nephrology (Carlton) 2012;17:346-51.
64. Krasoudaki E, Stagakis E, Loupasakis K, Papagianni A, Alexopoulos E, Bertsias G et al. MicroRNA analysis of human lupus nephritis: evidence for modulation of kallikrein 4 by miR-422a. Ann Rheum Dis 2012;71S3:472 SAT0006 (Abstract).
65. Kalunian K, Merrill JT, Maciuca R, Ouyang W, McBride JM, Townsend MJ et al. Efficacy and safety of Rontalizumab (antiinterferon alpha) in SLE subjects with restricted immunosuppressant use: results of a randomized, double-blind, placebo-controlled phase 2 study. Arthritis Rheum 2012;4:No 10 (S1111) (Abstract).
66. Wang C, Sandling JK, Hagberg N, Berggren O, Sigurdsson S, Karlberg O et al. Genome-wide profiling of target genes for the systemic lupus erythematosus-associated transcription factors IRF5 and STAT4. Ann Rheum Dis 2013;72:96-103.
67. Feng D, Stone CR, Eloranta ML, Sangster-Guity N, Nordmark G et al. Genetic variants and disease-associated factors contribute to enhanced interferon regulatory factor 5 expression in blood cells of patients with systemic lupus erythematosus. Arthritis Rheum 2010;62:562-73.
68. Stone RC, Du P, Feng D, Dhawan K, Ronnblom L, Eloranta ML et al. RNA-Seq for enrichment and analysis of IRF5 transcript expression in SLE. PLoS ONE 2013;8:e54487.
69. Ernst J, Kheradpour P, Mikkelsen TS, Shoresh N, Ward LD, Epstein CB et al. Mapping and analysis of chromatin state dynamics in nine human cell types. Nature 2011;473:43-9.